ADenoVirus Initiative Study in Epidemiology in France
NCT02054234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 357
Last updated 2015-02-10
Summary
The objectives of this study is to assess the characteristics and frequency of adenovirus conjunctivitis in a population of male and female patients from one year of age who present signs and symptoms of acute conjunctivitis.
Conditions
- Viral Conjunctivitis
Sponsors & Collaborators
-
NicOx
lead INDUSTRY
Principal Investigators
-
Eric Tuil · CHNO Des Quinze-Vingts
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734 ·Status: COMPLETED ·Phase: NA
-
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
NCT01470664 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
NCT02132169 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
NCT02492321 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
NCT02998541 ·Status: TERMINATED ·Phase: PHASE3
-
Reducing Adenoviral Patient Infected Days
NCT02472223 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NCT01532336 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
NCT00364091 ·Status: COMPLETED ·Phase: PHASE3
-
AGN-229666 for the Treatment of Allergic Conjunctivitis
NCT01754766 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895 ·Status: COMPLETED ·Phase: NA
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
NCT02998554 ·Status: TERMINATED ·Phase: PHASE3
-
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01685242 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01881113 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis
NCT01156025 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
NCT01243983 ·Status: COMPLETED ·Phase: PHASE3
-
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
NCT03856645 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
NCT01089608 ·Status: COMPLETED ·Phase: PHASE2
-
FST-100 in the Treatment of Acute Viral Conjunctivitis
NCT01461954 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Corneal and External Diseases
NCT00008541 ·Status: COMPLETED
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
NCT01179412 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
NCT01977443 ·Status: COMPLETED ·Phase: PHASE2